Latest & greatest articles for Review of Systems

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Review of Systems or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Review of Systems and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Review of Systems

1. Pediatric hydrocephalus - Antibiotic-impregnated shunt systems versus conventional shunts in children: a systematic review and meta-analysis

Pediatric hydrocephalus - Antibiotic-impregnated shunt systems versus conventional shunts in children: a systematic review and meta-analysis 7. Antibiotic-impregnated shunt systems versus conventional shunts in children: a systematic review and meta-analysis - cns.org ');//]]> × To support the neurosurgery community in these unprecedented times, the CNS is offering complimentary online education. . Reposted with permission from ©AANS, 2014 J Neurosurg Pediatrics (Suppl) 14: 53–59, 2014 AANS (...) , 2014 (Used with permission from Journal of Neurosurgery: Pediatrics . Please click for the original publication.) Pediatric hydrocephalus: systematic literature review and evidence-based guidelines Part 7: Antibiotic-impregnated shunt systems versus conventional shunts in children: a systematic review and meta-analysis UPDATE Paul Klimo Jr. MD, MPH , 1–3 Clinton J. Thompson, PhD, 4 Lissa C. Baird, MD, 4 Ann Marie Flannery, MD 5 1 Semmes-Murphey Neurologic & Spine Institute; 2 Department

2020 Congress of Neurological Surgeons

2. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis Full Text available with Trip Pro

Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID (...) . doi: 10.1007/s40256-020-00439-5. Online ahead of print. Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis , , , , Affiliations Expand Affiliations 1 Department of Pharmacy, University of Huddersfield, Huddersfield, HD1 3DH, UK. s.hasan@hud.ac.uk. 2 School of Postgraduate Studies, International Medical University, Kuala Lumpur, 57000, Malaysia. 3 Institute of Clinical Sciences, University of Birmingham

2020 EvidenceUpdates

3. Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities Full Text available with Trip Pro

Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID (...) 10;22(11):90. doi: 10.1007/s11906-020-01101-w. Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities , , , , , Affiliations Expand Affiliations 1 Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Konstantinoupoleos 49, 54 642, Thessaloniki, Greece. 2 Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki

2020 EvidenceUpdates

4. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis Full Text available with Trip Pro

Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 (...) . Online ahead of print. Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta-analysis , Affiliations Expand Affiliation 1 Hypertension Section, Internal Medicine Department, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. PMID: 32767823 PMCID: DOI: Free PMC article Item in Clipboard Review Use of inhibitors of the renin-angiotensin system in hypertensive patients and COVID-19 severity: A systematic review and meta

2020 EvidenceUpdates

5. Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials

Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly (...) ahead of print. Comparison of catheter and surgical ablation of atrial fibrillation: A systemic review and meta-analysis of randomized trials , , , , Affiliations Expand Affiliations 1 Department of Cardiovascular Surgery, the First Affiliated Hospital, Nanjing Medical University, Nanjing, China. 2 Department of Geriatric Intensive Care Unit, the First Affiliated Hospital, Nanjing Medical University, Nanjing, China. 3 State Key Laboratory of Reproductive Medicine, School of Public Health, Nanjing

2020 EvidenceUpdates

6. Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review. (Abstract)

Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review. Many patients with systemic amyloidosis are underdiagnosed. Overall, 25% of patients with immunoglobulin light chain (AL) amyloidosis die within 6 months of diagnosis and 25% of patients with amyloid transthyretin (ATTR) amyloidosis die within 24 months of diagnosis. Effective therapy exists but is ineffective if end-organ damage is severe.To provide evidence-based recommendations that could allow clinicians (...) independently selected and appraised relevant literature.There was a total of 1769 studies in the final data set. Eighty-one articles were included in this review, of which 12 were randomized clinical trials of therapy that included 3074 patients, 9 were case series, and 3 were cohort studies. The incidence of AL amyloidosis is approximately 12 cases per million persons per year and there is an estimated prevalence of 30 000 to 45 000 cases in the US and European Union. The incidence of variant ATTR

2020 JAMA

7. Systematic Review - Risk of Nephrogenic Systemic Fibrosis after Exposure to Newer Gadolinium

Systematic Review - Risk of Nephrogenic Systemic Fibrosis after Exposure to Newer Gadolinium ? October 2019 Prepared for: Department of Veterans Affairs Veterans Health Administration Health Services Research & Development Service Washington, DC 20420 Prepared by: Evidence Synthesis Program (ESP) Center Durham VA Healthcare System Durham, NC Karen M. Goldstein, MD, MSPH, Co-Director Jennifer M. Gierisch, PhD, MPH, Co-Director Risk of Nephrogenic Systemic Fibrosis after Exposure to Newer (...) and Cochrane Collaboration. The Coordinating Center was created to manage program operations, ensure methodological consistency and quality of products, and interface with stakeholders. To ensure responsiveness to the needs of decision-makers, the program is governed by a Steering Committee comprised of health system leadership and researchers. The program solicits nominations for review topics several times a year via the program website. Comments on this evidence report are welcome and can be sent

2020 Veterans Affairs Evidence-based Synthesis Program Reports

8. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis Full Text available with Trip Pro

The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features (...) Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Diabetes Metab Syndr Actions . 2020 Jun 27;14(5):983-990. doi: 10.1016/j.dsx.2020.06.047. Online ahead of print. The use of renin angiotensin system inhibitor on mortality in patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis , , , , , , , , , Affiliations Expand Affiliations 1 Faculty of Medicine

2020 EvidenceUpdates

9. Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National (...) of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation JAMA Psychiatry Actions . 2020 Jun 3;e200431. doi: 10.1001/jamapsychiatry.2020.0431. Online ahead of print. Psychosocial Interventions and Immune System Function: A Systematic Review and Meta-analysis of Randomized Clinical Trials , , Affiliations Expand Affiliations 1 Center for Mind and Brain, University of California, Davis. 2 Department of Psychology, San Diego State University, San Diego

2020 EvidenceUpdates

10. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. (Abstract)

Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. The risk for nephrogenic systemic fibrosis (NSF) after exposure to newer versus older gadolinium-based contrast agents (GBCAs) remains unclear.To synthesize evidence about NSF risk with newer versus older GBCAs across the spectrum of kidney function.MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science for English-language references from inception to 5 March 2020

2020 Annals of Internal Medicine

11. Integrating Health System Data With Systematic Reviews

Integrating Health System Data With Systematic Reviews Methods Research Report Integrating Health System Data With Systematic Reviews: A Framework for When and How Unpublished Health System Data Can Be Used With Systematic Reviews To Support Health System Decision Making Methods Research Report Integrating Health System Data With Systematic Reviews: A Framework for When and How Unpublished Health System Data Can Be Used With Systematic Reviews To Support Health System Decision Making Prepared (...) Portland, OR Investigators: Jennifer S. Lin, M.D., M.C.R. M. Hassan Murad, M.D. Brian Leas, M.S. Jonathan R. Treadwell, Ph.D. Roger Chou, M.D. Ilya Ivlev, M.D., Ph.D. Devan Kansagara, M.D., M.C.R. AHRQ Publication No. AHRQ 19 ( 2 0 )-EHC023-EF April 2020ii Key Messages Purpose of Report Given that health-system decision making would benefit from both traditional systematic reviews and health-system-specific data, this report investigates when and how to use primary data from health systems in real time

2020 Effective Health Care Program (AHRQ)

12. Review of information management practices in the HSE Computerised Infectious Disease Reporting (CIDR) system

Review of information management practices in the HSE Computerised Infectious Disease Reporting (CIDR) system Review of information management practices in the CIDR system Health Information and Quality Authority Page 1 of 146 Review of information management practices in the HSE Computerised Infectious Disease Reporting (CIDR) system November 2019 Review of information management practices in the CIDR system Health Information and Quality Authority Page 2 of 146 About the Health Information (...) and the HSE. Review of information management practices in the CIDR system Health Information and Quality Authority Page 3 of 146 Overview of the health information function of HIQA Health is information-intensive, generating huge volumes of data every day. Health and social care workers spend a significant amount of their time handling information, collecting it, looking for it and storing it. It is, therefore, very important that information is managed in the most effective way possible in order

2019 HIQA Health Information

13. Magnetic Resonance Imaging-Guided Radiotherapy Delivery Systems for Cancer Treatment: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines

Magnetic Resonance Imaging-Guided Radiotherapy Delivery Systems for Cancer Treatment: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines Magnetic Resonance Imaging-Guided Radiotherapy Delivery Systems for Cancer Treatment: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Magnetic Resonance Imaging-Guided Radiotherapy Delivery Systems for Cancer Treatment: A Review of Clinical Effectiveness, Cost-Effectiveness (...) and Guidelines Magnetic Resonance Imaging-Guided Radiotherapy Delivery Systems for Cancer Treatment: A Review of Clinical Effectiveness, Cost-Effectiveness and Guidelines Last updated: March 25, 2019 Project Number: RC1085-000 Product Line: Research Type: Devices and Systems Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of magnetic resonance imaging-guided radiotherapy delivery systems for the treatment of patients with cancer requiring

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

14. Interventions to manage use of the emergency and urgent care system by people from vulnerable groups: a mapping review Full Text available with Trip Pro

Interventions to manage use of the emergency and urgent care system by people from vulnerable groups: a mapping review Interventions to manage use of the emergency and urgent care system by people from vulnerable groups: a mapping review Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This review identified nine different types of interventions that may be useful in addressing the needs of particular vulnerable populations, but found little evidence relating specifically to these groups. {{author}} {{($index , , , , & . Andrew Booth , Louise Preston , * , Susan Baxter , Ruth Wong , Duncan Chambers , Janette Turner School of Health and Related Research, University

2019 NIHR HTA programme

15. Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. (Abstract)

Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review. Non-small cell lung cancer remains the leading cause of cancer death in the United States. Until the last decade, the 5-year overall survival rate for patients with metastatic non-small cell lung cancer was less than 5%. Improved understanding of the biology of lung cancer has resulted in the development of new biomarker-targeted therapies and led to improvements in overall survival for patients

2019 JAMA

16. Improving Access to and Usability of Systematic Review Data for Health Systems Guidelines Development

Improving Access to and Usability of Systematic Review Data for Health Systems Guidelines Development Methods Research Report Improving Access to and Usability of Systematic Review Data for Health Systems Guidelines Development Methods Research Report Improving Access to and Usability of Systematic Review Data for Health Systems Guidelines Development Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 (...) , such as clinical practice guidelines, other quality enhancement tools, or reimbursement or coverage policies may not be stated or implied. Persons using assistive technology may not be able to fully access information in this report. For assistance contact EffectiveHealthCare@ahrq.hhs.gov. Suggested citation: Totten AM, Smith C, Dunham K, Jungbauer RM, Graham E. Improving Access to and Usability of Systematic Review Data for Health Systems Guidelines Development. Methods Research Report. (Prepared

2019 Effective Health Care Program (AHRQ)

17. Systemic Antibiotics for the Treatment of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis

Systemic Antibiotics for the Treatment of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis Systemic Antibiotics for the Treatment of Skin and Soft Tissue Abscesses: A Systematic Review and Meta-Analysis Michael Gottlieb, MD*; Joshua M. DeMott, PharmD, MSc; Marilyn Hallock, MD, MS; Gary D. Peksa, PharmD *Corresponding Author. E-mail: michaelgottliebmd@gmail.com, Twitter: @MGottliebMD. Study objective: The addition of antibiotics to standard incision and drainage (...) is controversial, with earlier studies demonstrating no signi?cant bene?t. However, 2 large, multicenter trials have recently been published that have challenged the previous literature. The goal of this review was to determine whether systemic antibiotics for abscesses after incision and drainage improve cure rates. Methods: PubMed, the Cumulative Index of Nursing and Allied Health Literature, Scopus, the Cochrane Database of Systematic Reviews, the Cochrane Central Register of Controlled Trials

2018 Annals of Emergency Medicine Systematic Review Snapshots

18. Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers

Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers Methods Research Report Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers Methods Research Report Development and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 (...) and Usability Testing of EPC Evidence Review Dissemination Summaries for Health Systems Decisionmakers. Methods Research Report. (Prepared by the University of Alberta Evidence- based Practice Center under Contract No. 290-290-2015-00001-I). AHRQ Publication No. 18(19)-EHC027-EF. Rockville, MD: Agency for Healthcare Research and Quality. November 2018. Posted final reports are located on the Effective Health Care Program search page. https://doi.org/10.23970/AHRQEPCMETHENGAGEDEVELOPMENT. iv Preface

2018 Effective Health Care Program (AHRQ)

19. Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature Full Text available with Trip Pro

Bladder Malakoplakia in Systemic Sclerosis Patient: A Case Report and Review Literature Malakoplakia, an anecdotal reactive granulomatous lesion, is a rare pathologic entity but relatively more common in genitourinary tracts. Here we report a case of malakoplakia in the urinary bladder in systemic sclerosis. The patient was a 66-year-old female treated with long-term corticosteroid and cyclophosphamide. She presented with gross hematuria, and cystoscopy and biopsy revealed malakoplakia (...) . There was no tumor and the stains for infectious organism were all negative. To the best of our knowledge, this is the first case report of malakoplakia in a systemic sclerosis patient.

2018 Journal of endourology case reports

20. Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: New insights and review Full Text available with Trip Pro

Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: New insights and review Ultrasonography has been rarely used to measure musculoskeletal and joint activity in systemic lupus erythematosus (SLE). The aim of this review is to discuss the utility and reliability of this non-invasive diagnostic tool for the assessment of joint disease in SLE patients. In the last decade, several reports have highlighted the role of ultrasonography for a better evaluation

2018 European journal of rheumatology